Benign Prostatic Hyperplasia (BPH)

Open Clinical Trials

BPH Study – Medi-Tate Protocol MT-03

A Phase II, randomized, controlled, multicenter clinical study evaluating the safety and effectiveness of the Medi-Tate Temporary Implantable Nitinol Device (iTIND) in patients with symptomatic Benign Prostatic Hyperplasia (BPH).

---

Learn More

If you would like more information about this current clinical study, please contact us:

Phone: 516-931-0041